Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Effect of Levetiracetam on Depression and Anti-Oxidant Activity in Patients With Epilepsy Publisher



Mehvarihabibabadi J1 ; Zare M1 ; Aghayeghazvini MR2 ; Rahnama M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. National Institute of Health Research, Tehran University of Medical Sciences, Tehran, Iran

Source: Current Journal of Neurology Published:2022


Abstract

Background: Levetiracetam (LEV) is approved for treating epilepsy. The current evidence shows that LEV can cause behavioral problems such as depression. It is well-known that depression is associated with oxidative stress. Therefore, we conducted this study to assess the influence of LEV on depression severity and anti-oxidant status. Methods: In this prospective longitudinal study, 50 patients with diagnosis of epilepsy on LEV were included. We used Beck Depression Inventory-II (BDI-II) to assess depression severity. The serum levels of zinc and glutathione were measured as anti-oxidant markers. These variables were evaluated at the baseline and 3 months after the commencement of LEV. Results: A total of 30 patients finished the follow-up. Among them, 21 patients were women. The mean age at baseline was 28.76 ± 11.37 (range: 16-68 years). The severity of depression at the last follow-up was significantly higher than the baseline. We observed a decrease in the serum levels of zinc and glutathione, though they were not statistically significant. Conclusion: Our results suggest that LEV can increase the risk of depression in patients with epilepsy. This study also suggests that zinc depletion can be induced through act of LEV. Further studies are needed to validate these findings. © 2022 Iranian Neurological Association, and Tehran University of Medical Sciences Published by Tehran University of Medical Sciences.
Related Docs
View other Related Docs
1. Effect of Levetiracetam Drug on Antioxidant and Liver Enzymes in Epileptic Patients: Case-Control Study, African Health Sciences (2020)
2. Vitamin B12 and Folate Status in Patients With Epilepsy Under Levetiracetam Monotherapy, International Journal of Preventive Medicine (2019)
3. The Efficacy of Vitamin B6 and Alpha-Lipoic Acid in Preventing Levetiracetam Depressant-Like Behavior in Mice, Thai Journal of Pharmaceutical Sciences (2022)
4. The Oxidative Status and Na+/K+-Atpase Activity in Obsessive-Compulsive Disorder: A Case Control Study, BioMed Research International (2024)
5. Dietary Intake of Branched-Chain Amino Acids in Relation to Depression, Anxiety and Psychological Distress, Nutrition Journal (2021)
6. Low Serum Zinc Level in Depression, Journal of Research in Medical Sciences (2006)
7. Betahistine, Prevents Kindling, Ameliorates the Behavioral Comorbidities and Neurodegeneration Induced by Pentylenetetrazole, Epilepsy and Behavior (2020)
8. Clinical Effectiveness of Zinc Supplementation on the Biomarkers of Oxidative Stress: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Pharmacological Research (2020)
Experts (# of related papers)
View all Related Experts
Vahid Shaygannejad (2)
Mohammad Reza Najafi (2)
Other Related Docs
9. Sexual Dysfunction in Women With Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis, Sexuality and Disability (2022)
10. Vitamin D Supplementation Affects the Beck Depression Inventory, Insulin Resistance, and Biomarkers of Oxidative Stress in Patients With Major Depressive Disorder: A Randomized, Controlled Clinical Trial, Journal of Nutrition (2016)
11. Association of Mood Disorders With Serum Zinc Concentrations in Adolescent Female Students, Biological Trace Element Research (2017)
12. Effect of Zinc Supplementation on Physical and Psychological Symptoms, Biomarkers of Inflammation, Oxidative Stress, and Brain-Derived Neurotrophic Factor in Young Women With Premenstrual Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial, Biological Trace Element Research (2020)
13. Comparative Effect of Intravenous Ketamine and Electroconvulsive Therapy in Major Depression: A Randomized Controlled Trial, Advanced Biomedical Research (2019)
14. Anti-Ribosomal P Antibodies Related to Depression in Early Clinical Course of Systemic Lupus Erythematosus, Journal of Research in Medical Sciences (2013)
15. Associations Between Dietary Intake of B-Vitamins and Psychological Disorders Among Iranian Women: A Cross-Sectional Study, Public Health Nutrition (2021)
16. Intravenous Ketamine Therapy Vs. Electroconvulsive Therapy in Depressive Cases, Journal of Isfahan Medical School (2012)
17. Association of Omega-3 Fatty Acid and Epileptic Seizure in Epileptic Patients: A Systematic Review, International Journal of Preventive Medicine (2018)
18. Effect of Low-Carbohydrate Diet on Depression and Anxiety: A Systematic Review and Meta-Analysis of Controlled Trials, Journal of Affective Disorders (2023)
19. Comparison of Sleep Complaints and Quality of Life Between Patients With Neuromyelitis Optica Spectrum Disorder (Nmosd) and Healthy Controls, Multiple Sclerosis and Related Disorders (2019)
20. Depression and Anxiety and Their Related Factors in Non-Cystic Fibrosis Stable Bronchiectasis, Immunopathologia Persa (2021)
21. Efficacy and Safety of Peginterferon Beta-1A Compared to Interferon Beta-1A in Relapsing Remitting Multiple Sclerosis Patients: A Phase 3, Randomized, Non-Inferiority Clinical Trial (Pegintegrity), Multiple Sclerosis and Related Disorders (2024)
22. Efficacy of Levetiracetam in Children With Refractory Epilepsy As an Add-On Trial, Epilepsy Research (2010)
23. Zinc in Thalassemic Patients and Its Relation With Depression, Biological Trace Element Research (2008)
24. The Efficacy and Safety of Fluoxetine Delayed-Release 90 Mg/Weekly in Psychiatry: An Evidence-Based Mini-Review, Iranian Journal of Psychiatry and Behavioral Sciences (2024)